Skip to main content
. 2014 Jan 17;9(1):e85514. doi: 10.1371/journal.pone.0085514

Table 1. Effect of recombinant TCTP in the progression of cell cycle from B cells.

Time (h) Ap G1 S G2M Incorporation
0 HsTCTP 0.0±0.0 81.7±3.5 8.5±1.1 9.7±2.4 3.7±0.3
PfTCTP 0.0±0.0 71.3±5.3 10.9±3.3 17.8±2.1 1.7±0.1
24 HsTCTP 34.7±2.4 53.5±3.4 8.4±1.2 3.4±0.2 22.5±2.5
PfTCTP 43.3±3.4 48.8±1.2 6.0±1.8 2.0±0.4 33.0±1.2
48 HsTCTP 10.8±3.3 43.5±4.8 26.1±1.5 19.6±0.1 33.9±1.0
PfTCTP 35.9±4.0 37.2±3.7 20.7±1.6 6.3±1.9 43.6±0.8
72 HsTCTP 14.1±1.5 33.8±1.5 29.8±1.3 22.3±1.3 38.1±3.0
PfTCTP 43.6±0.5 32.8±0.2 14.0±0.4 9.6±0.2 52.4±0.9
96 HsTCTP 26.0±2.3 46.5±2.7 13.9±0.6 13.5±1.1 39.0±0.7
PfTCTP 41.4±3.4 34.6±0.3 20.1±3.7 3.8±0.1 72.4±2.1*
120 HsTCTP 50.8±4.3 37.1±3.3 8.3±0.8 3.8±0.2 54.9±0.3
PfTCTP 61.3±6.9 19.3±2.2 17.0±4.0 2.4±0.7 96.4±0.9**

Splenic B cells (2×106cells/well) were plated with RPMI 1640 supplemented with 10% FBS and incubated with 10 µg/mL of recombinant HsTCTP or PfTCTP labeled with Oregon Green 488 (green) fluorochrome for 24–120 h at 37°C and 5% CO2. The percentage of cell cycle distribution and incorporation of fluorescently-labeled of PfTCTP and HsTCTP into splenic B cells was analyzed by flow cytometry (FACS). Results (%) are expressed as mean ± SD of duplicate determinations. One of two similar experiments is shown. Incorporation, percentage of incorporation of fluorescently-labeled protein into B cells.

*, p<0.05 vs 10 µg/mL labeled HsTCTP treated B cells

**, p<0.01 vs 10 µg/mL labeled HsTCTP treated B cells